This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
CRA surveyed 36 MedTech leaders to understand their strategic priorities and the impact of COVID-19 on their business.
Survey respondents work in leadership positions in major companies including Abbott, Boston Scientific, Depuy, Medtronic, Olympus, Philips Healthcare, Roche, Smith & Nephew, Zimmer-Biomet, and more.
Download the output summary here:
Digital therapeutics (DTx) leverage technology to deliver evidence-based treatments for various health conditions, aiming to complement or replace traditional...
The global medical devices market is projected to grow at 4.4% CAGR until 2025. But large medical devices with high initial procurement costs are experiencing...
